NY State Senate Bill S8575

Archive: Last Bill Status - Passed Senate

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed/Vetoed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (7)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
May 18, 2022	referred to health delivered to assembly passed senate
May 09, 2022	advanced to third reading
May 05, 2022	2nd report cal.
May 04, 2022	1st report cal.1077
Mar 15, 2022	referred to women's issues

Votes

view votes

May 18, 2022 - floor Vote

S8575

floor

Aye

Nay

Absent

Excused

Abstained

May 4, 2022 - Women's Issues committee Vote

S8575

committee

Aye

Nay

Aye with Reservations

Absent

Excused

Abstained

Co-Sponsors

S8575 (ACTIVE) - Details

See Assembly Version of this Bill:: A9446
Current Committee:: Assembly Health
Law Section:: Public Health Law
Laws Affected:: Add Art 2 Title 6 §267-a, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:: S3219, A1087

S8575 (ACTIVE) - Summary

Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.

S8575 (ACTIVE) - Sponsor Memo

 
BILL NUMBER: S8575

SPONSOR: CLEARE
 
TITLE OF BILL:

An act to amend the public health law, in relation to establishing a
uterine fibroids awareness and education program

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill would amend title 6 of article 2 of the public health law to
add a new section that would have the department of health conduct an
ongoing public awareness campaign for the diagnosis and treatment of
fibroids

 
SUMMARY OF PROVISIONS:

Section 1: Amends title 6 of article 2 of the public health law to
create a uterine fibroid awareness program that will distribute educa-
tional materials that will inform people on the elevated risks of
uterine fibroids for minority women, symptoms of uterine fibroids and
available treatment. The department of health will periodically review

available data on fibroids and report their findings every three years
to the state and make further

 
JUSTIFICATION:

While fibroids are a common issue faced by woman across the US, informa-
tion about what fibroids are and the issues they cause are often unknown
by the general public. Black women and women of color may not be aware
of the elevated risks that they have to developing fibroids. It is
important that the seriousness of this issue is communicated to the
public so that people with fibroids can take the steps to treat them and
manage their symptoms.

Placing signage in doctor's offices where women who may be affected by
fibroids can see is important. This will provide them with information
that they can use to talk to their doctor. Some women may be experienc-
ing fibroid symptoms and not realize that they have fibroids. It is
imperative that women understand what fibroids are and can use that
information to advocate for themselves and their treatment. Providing
information in this way through pamphlets and educational materials will
help women treat fibroid symptoms earlier and provide awareness of this
diagnosis.

 
PRIOR LEGISLATIVE HISTORY:

New Bill

 
FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS:

To be determined

 
EFFECTIVE DATE:
This act shall take effect on the one hundred eightieth day after it
shall have become a law. Effective immediately, the addition, amendment
and/or repeal of any rule or regulation necessary for the implementation
of this act on its effective date are authorized to be made and 7
completed on or before such effective date.

S8575 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8575
 
                             I N  S E N A T E
 
                              March 15, 2022
                                ___________
 
 Introduced  by  Sen.  CLEARE -- read twice and ordered printed, and when
   printed to be committed to the Committee on Women's Issues
 
 AN ACT to amend the public health law, in  relation  to  establishing  a
   uterine fibroids awareness and education program
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Title 6 of article 2 of the public health law, as added  by
 chapter  342  of  the  laws  of 2014, is amended by adding a new section
 267-a to read as follows:
   § 267-A.  UTERINE FIBROIDS AWARENESS AND  EDUCATION  PROGRAM.  1.  THE
 DEPARTMENT  SHALL  CONDUCT  AN  ONGOING  PUBLIC  AWARENESS AND EDUCATION
 PROGRAM UNDER SECTION TWO HUNDRED SEVEN OF THIS ARTICLE ON THE SYMPTOMS,
 DIAGNOSIS AND TREATMENT OF UTERINE FIBROIDS AND THE  ELEVATED  RISK  FOR
 MINORITY WOMEN.
   2.  THE  DEPARTMENT SHALL PRODUCE AND DISTRIBUTE EDUCATIONAL MATERIALS
 ON THE ELEVATED RISKS OF UTERINE FIBROIDS FOR MINORITY  WOMEN,  SYMPTOMS
 OF  UTERINE  FIBROIDS  AND AVAILABLE TREATMENTS. SUCH MATERIALS SHALL BE
 MADE AVAILABLE TO APPROPRIATE HEALTH CARE PROVIDERS FOR DISTRIBUTION  TO
 PATIENTS. THE DEPARTMENT SHALL ALSO PROVIDE INFORMATION ON THE SYMPTOMS,
 DIAGNOSIS  AND  TREATMENT  OF UTERINE FIBROIDS AND THE ELEVATED RISK FOR
 MINORITY WOMEN ON THE DEPARTMENT'S INTERNET  WEBSITE.  NO  PROVISION  OF
 THIS  SUBDIVISION  SHALL  BE  DEEMED  TO  PROHIBIT  THE  UTILIZATION AND
 DISTRIBUTION OF EDUCATIONAL MATERIALS RELATING THERETO PRODUCED  BY  ANY
 PUBLIC,  PRIVATE  OR  GOVERNMENTAL  ENTITY,  IN LIEU OF THE DEPARTMENT'S
 PRODUCTION OF SUCH MATERIALS.
   3. THE DEPARTMENT SHALL PERIODICALLY  REVIEW  AVAILABLE  DATA  ON  THE
 SYMPTOMS,  DIAGNOSIS  AND TREATMENT OF UTERINE FIBROIDS AND THE ELEVATED
 RISK FOR MINORITY WOMEN AND  UPDATE  THE  INFORMATION  PROVIDED  IN  ITS
 EDUCATIONAL MATERIALS AND ON ITS INTERNET WEBSITE, AS APPROPRIATE.
   4.  THE  DEPARTMENT SHALL REPORT EVERY THREE YEARS, COMMENCING JANUARY
 FIRST, TWO THOUSAND TWENTY-FIVE, TO THE GOVERNOR, THE  TEMPORARY  PRESI-
 DENT OF THE SENATE AND THE SPEAKER OF THE ASSEMBLY ON THE IMPLEMENTATION
 OF  THIS  SECTION  AND ANY RECOMMENDATIONS FOR FURTHERING THE PURPOSE OF
 THIS SECTION.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

                                                            LBD14343-01-2
 S. 8575                             2
 
   5. IMPLEMENTATION OF THIS SECTION SHALL BE CONTINGENT UPON  AND  SHALL
 BE CONDUCTED WITHIN APPROPRIATIONS MADE THEREFOR.
   § 2. This act shall take effect on the one hundred eightieth day after
 it  shall have become a law. Effective immediately, the addition, amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation of this act on its effective date are authorized to be  made  and
 completed on or before such effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S8575

Sponsored By

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

May 18, 2022 - floor Vote

Floor Vote: May 18, 2022

May 4, 2022 - Women's Issues committee Vote

Women's Issues Committee Vote: May 4, 2022

Co-Sponsors

S8575 (ACTIVE) - Details

S8575 (ACTIVE) - Summary

S8575 (ACTIVE) - Sponsor Memo

S8575 (ACTIVE) - Bill Text download pdf

Comments

senate Bill S8575

Share this bill

Sponsored By

Cordell Cleare

Archive: Last Bill Status - Passed Senate

Your Voice

Actions

Votes

May 18, 2022 - floor Vote

Floor Vote: May 18, 2022

May 4, 2022 - Women's Issues committee Vote

Women's Issues Committee Vote: May 4, 2022

Co-Sponsors

Luis R. Sepúlveda

Alexis Weik

S8575 (ACTIVE) - Details

S8575 (ACTIVE) - Summary

S8575 (ACTIVE) - Sponsor Memo

S8575 (ACTIVE) - Bill Text download pdf

Comments